| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Aspirin 81mg/Esomeprazole 20mg |
| Brand | Axanum® |
| Indication | Prevention of thrombotic cardiovascular and cerebrovascular events in patients requiring continuous low-dose acetylsalicylic acid treatment, and who are in need of prophylaxis against acetylsalicylic acid associated gastric and /or duodenal ulcers. |
| Assessment Process | |
| Rapid review commissioned | 12/04/2012 |
| Rapid review completed | 20/04/2012 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |
